Australia’s NHMRC reports on progress to improve clinical trials
The National Health and Medical Research Council (NHMRC), tasked with implementing a range of initiatives designed to make the process of initiating and conducting clinical trials in Australia significantly more efficient and cost-effective, has reported on the progress of work under the initiative and advised it will update the information monthly.
The work, under the Australian government’s Accelerating Clinical Trials Reforms initiative, was prompted by the 11 recommendations of the former Clinical Trials Action Group (CTAG), which has since been superseded as the Clinical Trial Advisory Committee (CTAC).
The initiatives are aimed at keeping Australia competitive as a destination for clinical trials and have three broad aims:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze